Understanding the NASH Market Revolution The healthcare industry is witnessing a remarkable transformation in liver disease management, particularly within the Nonalcoholic Steatohepatitis Market. This progressive liver condition, affecting millions of patients worldwide, has evolved from a relatively unknown disease to a major therapeutic focus area. The market’s evolution reflects the growing recognition of NASH as Read.